0,859  0,005  Caspase 9 stimulant
0,775  0,004  Tubulin antagonist
0,761  0,013  Antineoplastic (breast cancer)
0,760  0,012  Antineoplastic (lung cancer)
0,736  0,011  Antineoplastic (colorectal cancer)
0,729  0,011  Antineoplastic (colon cancer)
0,718  0,028  Apoptosis agonist
0,679  0,011  Prostate cancer treatment
0,647  0,003  Alpha tubulin antagonist
0,647  0,009  Cardiovascular analeptic
0,638  0,010  Antineoplastic (cervical cancer)
0,631  0,009  NOS2 expression inhibitor
0,643  0,026  Transcription factor NF kappa B inhibitor
0,621  0,006  Antimitotic
0,627  0,015  Aldehyde oxidase inhibitor
0,609  0,003  Beta tubulin antagonist
0,609  0,011  UGT1A9 substrate
0,610  0,016  Antihypercholesterolemic
0,602  0,010  Antineoplastic (non-small cell lung cancer)
0,592  0,015  5 Hydroxytryptamine release stimulant
0,585  0,028  TNF expression inhibitor
0,574  0,018  Antineoplastic (ovarian cancer)
0,565  0,019  Vasodilator, peripheral
0,561  0,017  Antineoplastic (melanoma)
0,564  0,029  Antileukemic
0,538  0,006  UGT2B4 substrate
0,559  0,033  CYP3A4 substrate
0,540  0,015  Caspase 3 stimulant
0,539  0,014  Antineoplastic (multiple myeloma)
0,541  0,017  Antineoplastic (pancreatic cancer)
0,525  0,018  Ulceration
0,507  0,005  Calcium channel activator
0,502  0,007  Antineoplastic (squamous cell carcinoma)
0,535  0,041  Antineoplastic (solid tumors)
0,504  0,010  RNA-directed DNA polymerase inhibitor
0,512  0,030  Antipruritic, allergic
0,486  0,009  P-glycoprotein inhibitor
0,495  0,021  Antioxidant
0,491  0,020  Antineoplastic (glioma)
0,471  0,005  Pneumotoxic
0,480  0,022  Cytostatic
0,468  0,018  Antineoplastic (glioblastoma multiforme)
0,469  0,022  Chemopreventive
0,467  0,026  AR expression inhibitor
0,457  0,017  UGT1A6 substrate
0,449  0,010  Hepatoprotectant
0,464  0,028  Hepatic disorders treatment
0,455  0,021  Free radical scavenger
0,450  0,020  Hypoxia-inducible factor 1 alpha inhibitor
0,440  0,011  Antineoplastic (carcinoma)
0,418  0,015  Antimutagenic
0,416  0,014  UGT1A4 substrate
0,416  0,024  Nitric oxide antagonist
0,416  0,025  Antipyretic
0,412  0,027  Proliferative diseases treatment
0,396  0,012  UGT1A3 substrate
0,414  0,031  Vasodilator, coronary
0,416  0,034  CTGF expression inhibitor
0,398  0,017  Sodium/bile acid cotransporter inhibitor
0,397  0,016  Antineoplastic (sarcoma)
0,414  0,035  Cardioprotectant
0,406  0,036  Lipoxygenase inhibitor
0,380  0,010  Tyrosine 3 hydroxylase inhibitor
0,379  0,010  UGT2B15 substrate
0,421  0,056  Immunosuppressant
0,418  0,053  CYP2C19 inhibitor
0,403  0,039  Antineoplastic (brain cancer)
0,376  0,012  VCAM1 expression inhibitor
0,377  0,015  Antiseptic
0,372  0,011  Lipid peroxidase inhibitor
0,395  0,035  Chemoprotective
0,399  0,040  Spasmolytic
0,368  0,010  Antineoplastic (gastric cancer)
0,359  0,003  UGT2B10 substrate
0,382  0,028  Antineoplastic (renal cancer)
0,380  0,026  Antineoplastic (osteosarcoma)
0,412  0,059  CYP2C9 substrate
0,373  0,021  Abortion inducer
0,388  0,038  Cytotoxic
0,371  0,021  Cyclic AMP phosphodiesterase inhibitor
0,382  0,032  DNA damaging
0,376  0,031  Tumour necrosis factor alpha release inhibitor
0,388  0,045  ICAM1 expression inhibitor
0,386  0,043  12-Lipoxygenase inhibitor
0,386  0,046  Teratogen
0,355  0,017  UGT2B7 substrate
0,374  0,037  Sensitization
0,359  0,022  Antineoplastic (bladder cancer)
0,448  0,111  Antiinflammatory
0,364  0,030  Vasodilator
0,356  0,022  UGT1A1 substrate
0,342  0,010  Acetylcholinesterase inhibitor
0,344  0,014  Amylase inhibitor
0,353  0,025  5 Hydroxytryptamine uptake stimulant
0,358  0,033  Amyloid beta aggregation inhibitor
0,341  0,020  Antihypotensive
0,332  0,011  Neurotrophic factor enhancer
0,365  0,047  CYP2C19 substrate
0,370  0,058  Antithrombotic
0,347  0,038  Cardiodepressant
0,336  0,033  Antineoplastic (lymphocytic leukemia)
0,388  0,086  5 Hydroxytryptamine release inhibitor
0,355  0,054  Respiratory analeptic
0,327  0,028  Sedative
0,358  0,061  Cholesterol antagonist
0,332  0,039  Transcription factor STAT3 inhibitor
0,325  0,033  GST M1-1 substrate
0,342  0,052  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,320  0,031  UDP-glucuronosyltransferase substrate
0,307  0,021  Antipruritic, non-allergic
0,372  0,087  15-Lipoxygenase inhibitor
0,348  0,063  FMO1 substrate
0,303  0,018  Cholinergic
0,302  0,020  Interferon gamma antagonist
0,313  0,035  Antihypertriglyceridemic
0,292  0,018  Genotoxic
0,297  0,023  Contraceptive
0,323  0,050  CYP1A2 inhibitor
0,324  0,054  Embryotoxic
0,319  0,057  Antineoplastic (small cell lung cancer)
0,277  0,016  NADPH oxidase inhibitor
0,270  0,013  Cystathionine beta-synthase inhibitor
0,262  0,007  Dopamine D1 antagonist
0,287  0,033  Antiviral (Influenza)
0,302  0,049  Vascular (periferal) disease treatment
0,328  0,074  Bone diseases treatment
0,266  0,016  UGT2B9 substrate
0,315  0,067  Analeptic
0,299  0,052  Antineoplastic (liver cancer)
0,349  0,103  Antibacterial
0,261  0,018  Heat shock protein 90 antagonist
0,252  0,008  Microtubule formation inhibitor
0,304  0,064  Antiosteoporotic
0,367  0,128  Alpha-glucosidase inhibitor
0,244  0,007  Arachidonic acid antagonist
0,256  0,019  Antineoplastic (bone cancer)
0,247  0,013  Expectorant
0,289  0,055  Antiamyloidogenic
0,260  0,027  Melanin inhibitor
0,338  0,105  Histamine release inhibitor
0,304  0,073  NOS3 expression inhibitor
0,287  0,057  Antidiabetic symptomatic
0,309  0,079  Apoptosis antagonist
0,246  0,023  LDLR expression enhancer
0,266  0,043  Anesthetic general
0,245  0,025  Topoisomerase II inhibitor
0,291  0,072  CYP1A2 substrate
0,279  0,061  Antiprotozoal (Leishmania)
0,225  0,012  Choleretic
0,278  0,069  Transcription factor STAT inhibitor
0,237  0,027  Succinate dehydrogenase inhibitor
0,238  0,028  Antiviral (Influenza A)
0,250  0,042  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,223  0,015  Toll-Like receptor 2 antagonist
0,236  0,030  Protein kinase stimulant
0,210  0,004  UGT2B11 substrate
0,311  0,105  GST A substrate
0,262  0,062  Antineoplastic (lymphoma)
0,246  0,057  Antineoplastic enhancer
0,220  0,031  Toxic, respiratory center
0,195  0,010  Dopamine agonist
0,275  0,093  Antifungal
0,254  0,072  Superoxide dismutase inhibitor
0,249  0,067  DNA synthesis inhibitor
0,185  0,008  CDC25A inhibitor
0,230  0,053  Sigma receptor agonist
0,223  0,047  Muscle relaxant
0,195  0,019  SULT1A1 substrate
0,190  0,015  Photosensitizer
0,214  0,039  VEGF expression inhibitor
0,191  0,020  Alpha 2c adrenoreceptor antagonist
0,226  0,054  Non-steroidal antiinflammatory agent
0,189  0,018  UGT2B1 substrate
0,178  0,007  Antifungal (Pneumocystis)
0,207  0,036  Antidote
0,184  0,014  Antiviral (Influenza B)
0,207  0,039  Skeletal muscle relaxant
0,192  0,026  Alpha 2b adrenoreceptor antagonist
0,223  0,057  Nitric-oxide synthase stimulant
0,188  0,023  Cyclooxygenase 3 inhibitor
0,228  0,063  Platelet aggregation inhibitor
0,171  0,008  Acetylcholine release stimulant
0,217  0,056  CYP2B6 inhibitor
0,274  0,113  Antineoplastic (endocrine cancer)
0,194  0,034  Antifungal enhancer
0,171  0,013  Contraceptive male
0,193  0,035  Antiprotozoal (Coccidial)
0,204  0,047  Heat shock protein 90 alpha antagonist
0,193  0,038  Carcinogenic, group 1
0,180  0,026  Antihelmintic (Trematoda)
0,185  0,031  Cholesterol synthesis inhibitor
0,240  0,086  5 Hydroxytryptamine 1E antagonist
0,216  0,063  Platelet adhesion inhibitor
0,188  0,035  SULT1A3 substrate
0,164  0,012  Anabolic
0,156  0,004  Heat shock protein 90 beta antagonist
0,191  0,040  Antidiarrheal
0,167  0,016  Prolactin inhibitor
0,178  0,027  Adenylate cyclase stimulant
0,170  0,020  Antineoplastic (uterine cancer)
0,190  0,040  Skin whitener
0,178  0,029  Antihemorrhagic
0,235  0,086  Hypoglycemic
0,179  0,031  Antieczematic
0,194  0,046  Antirickettsial
0,153  0,006  Dopamine D2 agonist
0,241  0,094  Radiosensitizer
0,169  0,023  Contraceptive female
0,172  0,026  Antineoplastic antibiotic
0,171  0,026  Coagulant
0,219  0,075  Antiulcerative
0,156  0,012  Aromatase inhibitor
0,176  0,033  Antitussive
0,162  0,019  Androgen antagonist
0,215  0,073  Antialcoholic
0,158  0,016  Antiprotozoal (Toxoplasma)
0,160  0,020  Estrogen antagonist
0,144  0,005  Topoisomerase II beta inhibitor
0,162  0,024  Sulfotransferase substrate
0,162  0,024  Alpha 2 adrenoreceptor antagonist
0,162  0,024  Antineoplastic alkaloid
0,205  0,068  Carcinogenic
0,158  0,022  Topoisomerase II alpha inhibitor
0,176  0,040  CF transmembrane conductance regulator agonist
0,160  0,026  Constipation treatment
0,166  0,032  5-Lipoxygenase inhibitor
0,155  0,023  Multidrug resistance-associated protein 1 inhibitor
0,148  0,016  SULT1E1 substrate
0,158  0,026  Ca2+-transporting ATPase inhibitor
0,142  0,012  Estrogen agonist
0,215  0,085  Hypolipemic
0,273  0,144  Antiprotozoal
0,190  0,063  Lipocortins synthesis antagonist
0,196  0,069  Mutagenic
0,140  0,014  HIV-1 integrase (Strand Transfer) inhibitor
0,154  0,030  Mucolytic
0,178  0,054  Hair growth stimulant
0,135  0,011  Glycine receptor antagonist
0,138  0,015  HIV-1 integrase (3'-Processing) inhibitor
0,173  0,050  Anesthetic
0,161  0,041  Alkylator
0,154  0,034  Vanilloid 1 agonist
0,143  0,025  DOPA decarboxylase inhibitor
0,175  0,057  Uterine stimulant
0,252  0,137  Antiprotozoal (Plasmodium)
0,149  0,036  Endometrios treatment
0,151  0,040  Topoisomerase I inhibitor
0,174  0,065  ATPase inhibitor
0,116  0,008  Dopamine D5 antagonist
0,133  0,026  Alpha 2a adrenoreceptor antagonist
0,111  0,005  SULT2A1 substrate
0,180  0,073  Dual specificity phosphatase 3 inhibitor
0,124  0,017  Estrogen receptor alpha antagonist
0,129  0,024  Estrogen receptor beta antagonist
0,199  0,094  Antiviral (HIV)
0,279  0,175  Calcium channel L-type activator
0,139  0,035  AMP-activated protein kinase stimulant
0,215  0,112  Lipoprotein disorders treatment
0,109  0,008  Estrogen receptor alpha agonist
0,133  0,032  Electron transport complex I inhibitor
0,186  0,088  Psychostimulant
0,103  0,005  Postcoital contraceptive
0,165  0,068  Eye irritation, high
0,172  0,075  Tumour necrosis factor antagonist
0,191  0,094  Antiparkinsonian, rigidity relieving
0,115  0,019  Granulocyte macrophage colony stimulating factor agonist
0,190  0,095  Antiparasitic
0,111  0,017  Narcotic antagonist
0,100  0,006  Transcription factor RelA inhibitor
0,149  0,056  Pregnane X receptor agonist
0,104  0,013  Androgen agonist
0,132  0,041  Butyrylcholinesterase inhibitor
0,229  0,139  Angiogenesis inhibitor
0,141  0,056  Antihyperlipoproteinemic
0,109  0,025  Keratolytic
0,112  0,028  Inducible nitric-oxide synthase inhibitor
0,178  0,097  Insulin sensitizer
0,151  0,072  Acaricide
0,111  0,032  Restless leg syndrome treatment
0,164  0,086  Phobic disorders treatment
0,099  0,021  Glycine receptor agonist
0,211  0,133  Gastrin inhibitor
0,108  0,030  ATPase (Vacuolar H+) inhibitor
0,181  0,104  Angiogenesis stimulant
0,127  0,051  Glutathione S-transferase substrate
0,145  0,069  Mannose-6-phosphate isomerase inhibitor
0,167  0,092  Antihelmintic
0,119  0,045  GST P1-1 substrate
0,099  0,026  Estrogen-related receptor beta agonist
0,098  0,026  HIV-1 integrase inhibitor
0,158  0,086  Dual specificity phosphatase inhibitor
0,207  0,136  CYP2D6 substrate
0,078  0,006  Dopamine D5 agonist
0,130  0,060  Antiviral (Hepatitis B)
0,115  0,047  Dementia treatment
0,141  0,073  Heat shock protein 70 antagonist
0,132  0,065  Antibacterial (Helicobacter pylori)
0,080  0,013  Estradiol 17 beta-dehydrogenase inhibitor
0,104  0,037  Interleukin 5 antagonist
0,102  0,038  Carbonic anhydrase VI inhibitor
0,087  0,022  5 Hydroxytryptamine 2A agonist
0,102  0,037  Antiviral (Trachoma)
0,111  0,047  Vascular dementia treatment
0,106  0,042  Paget's disease treatment
0,085  0,022  Aldose reductase inhibitor
0,100  0,038  Carbonic anhydrase XIII inhibitor
0,097  0,035  Na+ K+ transporting ATPase inhibitor
0,127  0,066  M18 aspartyl aminopeptidase inhibitor
0,145  0,084  Protein-tyrosine phosphatase inhibitor
0,065  0,004  Dopamine D1 agonist
0,088  0,027  Antitreponemal
0,144  0,083  Antiviral (Herpes)
0,077  0,018  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,081  0,022  Postmenopausal disorders treatment
0,098  0,039  Dopamine antagonist
0,108  0,049  Breast cancer-resistant protein inhibitor
0,073  0,014  Ryanodine receptor antagonist
0,076  0,018  Calcium channel P-type blocker
0,149  0,091  Interleukin 6 antagonist
0,071  0,013  Pregnane X receptor antagonist
0,153  0,096  3C-like protease (Human coronavirus) inhibitor
0,092  0,035  Histidine decarboxylase inhibitor
0,119  0,062  Monophenol monooxygenase inhibitor
0,122  0,067  Growth stimulant
0,147  0,092  Prostate disorders treatment
0,113  0,059  Protein kinase C gamma inhibitor
0,095  0,041  Opioid kappa receptor antagonist
0,129  0,074  Cocaine dependence treatment
0,153  0,100  DNA methyltransferase I inhibitor
0,101  0,049  Protein kinase C zeta inhibitor
0,148  0,096  Antipruritic
0,109  0,058  GABA C receptor agonist
0,160  0,109  DNA methylase inhibitor
0,129  0,078  Bone formation stimulant
0,123  0,072  Gastritis treatment
0,087  0,036  SULT1A2 substrate
0,070  0,022  Lipocortins synthesis agonist
0,184  0,137  Radioprotector
0,085  0,037  Dopamine D2 antagonist
0,063  0,015  Factor III inhibitor
0,102  0,055  Alpha adrenoreceptor antagonist
0,063  0,017  Estrogen receptor beta agonist
0,113  0,067  TRPA1 agonist
0,100  0,054  HIV-1 integrase (Overall Integration) inhibitor
0,096  0,051  Calcium antagonist
0,095  0,050  Ornithine decarboxylase inhibitor
0,201  0,155  Insulysin inhibitor
0,060  0,015  Progesterone antagonist
0,133  0,088  Peroxidase inhibitor
0,105  0,061  Toll-Like receptor 4 antagonist
0,120  0,077  Antiviral (Papilloma)
0,087  0,045  NAD(P)H dehydrogenase (quinone) inhibitor
0,084  0,043  Antibiotic
0,105  0,064  GST T1-1 substrate
0,094  0,053  Glutamate release inhibitor
0,141  0,102  Liver fibrosis treatment
0,048  0,009  Tubulin agonist
0,147  0,109  Neurotensin receptor agonist
0,060  0,022  Anesthetic inhalation
0,125  0,088  Antiparkinsonian, tremor relieving
0,098  0,062  Xanthine oxidase inhibitor
0,111  0,077  Carcinogenic, group 3
0,147  0,113  Phospholipase C inhibitor
0,098  0,064  Carbonic anhydrase III inhibitor
0,147  0,113  Catenin beta inhibitor
0,071  0,038  Glutamate (mGluR6) antagonist
0,084  0,053  Thioredoxin reductase inhibitor
0,044  0,013  Melatonin 2 agonist
0,082  0,052  Phosphodiesterase 3A inhibitor
0,079  0,049  MAP kinase kinase 7 inhibitor
0,060  0,031  Protein 50S ribosomal subunit inhibitor
0,106  0,076  5 Hydroxytryptamine 2B antagonist
0,115  0,086  Cyclooxygenase 1 inhibitor
0,161  0,133  Platelet antagonist
0,102  0,075  GABA C receptor antagonist
0,093  0,065  Bile acid receptor antagonist
0,082  0,054  Ca(v)3.1 blocker
0,065  0,038  Antimycoplasmal
0,098  0,071  Gout treatment
0,049  0,022  Guanylate cyclase inhibitor
0,064  0,039  Phosphodiesterase 1C inhibitor
0,127  0,102  NOS3 expression enhancer
0,111  0,086  Antiprotozoal (Amoeba)
0,126  0,102  Hemostatic
0,029  0,005  Progesterone receptor B antagonist
0,068  0,045  Phosphodiesterase III inhibitor
0,144  0,121  Antiarrhythmic
0,054  0,031  Prolyl endopeptidase inhibitor
0,104  0,082  Myasthenia Gravis treatment
0,094  0,072  Glutamate (mGluR7) agonist
0,121  0,100  Cytidine deaminase inhibitor
0,099  0,079  Protein-tyrosine phosphatase 1B inhibitor
0,065  0,046  Beta adrenoreceptor antagonist
0,068  0,048  Andropause treatment
0,128  0,109  GABA C receptor rho-2 antagonist
0,041  0,023  5-Alpha-reductase inhibitor
0,085  0,067  Antiadrenergic
0,068  0,050  Elastase 1 inhibitor
0,051  0,033  Squalene epoxidase inhibitor
0,082  0,064  mTOR complex 2 inhibitor
0,089  0,072  Creatine kinase inhibitor
0,081  0,066  Vanilloid agonist
0,051  0,036  Glucose-6-phosphate translocase inhibitor
0,084  0,069  Actinic keratosis treatment
0,078  0,063  Antispirochetal
0,062  0,047  CDC25B inhibitor
0,059  0,045  Antidote, heavy metal
0,059  0,044  Alpha 2 adrenoreceptor agonist
0,112  0,098  Toll-Like receptor antagonist
0,059  0,045  Dopamine D3 antagonist
0,081  0,067  Adrenaline antagonist
0,106  0,093  Alpha-N-acetylglucosaminidase inhibitor
0,193  0,179  FMO3 substrate
0,036  0,024  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,113  0,101  Antiprotozoal (Trichomonas)
0,059  0,048  Transcription factor AP-1 inhibitor
0,033  0,022  Glutamate (mGluR3) agonist
0,064  0,054  Glutamate (mGluR7) antagonist
0,082  0,072  Tocolytic
0,024  0,015  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,042  0,034  Dihydrofolate reductase inhibitor
0,082  0,074  Antischistosomal
0,040  0,032  Hypogonadism treatment
0,092  0,085  Beta glucuronidase inhibitor
0,068  0,061  Alpha 1 adrenoreceptor antagonist
0,179  0,173  Prostaglandin dehydrogenase inhibitor
0,016  0,010  NMDA receptor phencyclidine site antagonist
0,083  0,076  Protein kinase C mu inhibitor
0,112  0,106  Papain-like protease (SARS coronavirus) inhibitor
0,078  0,072  Opioid antagonist
0,031  0,026  Melatonin agonist
0,010  0,006  Progesterone receptor A antagonist
0,036  0,032  Glutamate (mGluR8) agonist
0,126  0,123  Muscular dystrophy treatment
0,060  0,057  Beta 3 adrenoreceptor antagonist
0,029  0,027  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,134  0,132  Pyruvate kinase inhibitor
0,041  0,040  Sigma receptor antagonist
0,019  0,018  Estrone sulfatase inhibitor
0,056  0,055  Bcl-xL inhibitor
0,023  0,023  Vanilloid 2 agonist
0,020  0,020  Prostaglandin F2 alpha agonist

